| Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity WS Lee, H Yang, HJ Chon, C Kim Experimental & molecular medicine 52 (9), 1475-1485, 2020 | 371 | 2020 |
| Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment JS Park, IK Kim, S Han, I Park, C Kim, J Bae, SJ Oh, S Lee, JH Kim, ... Cancer cell 30 (6), 953-967, 2016 | 309 | 2016 |
| Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis Y Kim, HJ Nam, J Lee, DY Park, C Kim, YS Yu, D Kim, SW Park, J Bhin, ... Nature communications 7 (1), 10347, 2016 | 214 | 2016 |
| STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade H Yang, WS Lee, SJ Kong, CG Kim, JH Kim, SK Chang, S Kim, G Kim, ... The Journal of clinical investigation 129 (10), 4350-4364, 2019 | 201 | 2019 |
| Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma C Kim, EK Kim, H Jung, HJ Chon, JW Han, KH Shin, H Hu, KS Kim, ... BMC cancer 16, 1-7, 2016 | 155 | 2016 |
| Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers CG Kim, JB Ahn, M Jung, SH Beom, C Kim, JH Kim, SJ Heo, HS Park, ... British journal of cancer 115 (1), 25-33, 2016 | 153 | 2016 |
| Differential prognostic implications of gastric signet ring cell carcinoma: stage adjusted analysis from a single high-volume center in Asia HJ Chon, WJ Hyung, C Kim, S Park, JH Kim, CH Park, JB Ahn, H Kim, ... Annals of surgery 265 (5), 946-953, 2017 | 149 | 2017 |
| Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma CG Kim, C Kim, SE Yoon, KH Kim, SJ Choi, B Kang, HR Kim, SH Park, ... Journal of hepatology 74 (2), 350-359, 2021 | 148 | 2021 |
| Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune-checkpoint blockade HJ Chon, WS Lee, H Yang, SJ Kong, NK Lee, ES Moon, J Choi, EC Han, ... Clinical Cancer Research 25 (5), 1612-1623, 2019 | 138 | 2019 |
| Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption C Kim, H Yang, Y Fukushima, PE Saw, J Lee, JS Park, I Park, J Jung, ... Cancer cell 25 (1), 102-117, 2014 | 132 | 2014 |
| SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation KS Seo, JH Park, JY Heo, K Jing, J Han, KN Min, C Kim, GY Koh, K Lim, ... Oncogene 34 (11), 1354-1362, 2015 | 120 | 2015 |
| Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer H Yang, C Kim, MJ Kim, RA Schwendener, K Alitalo, W Heston, I Kim, ... Molecular Cancer 10, 1-12, 2011 | 109 | 2011 |
| Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea MH Hong, HS Kim, C Kim, JR Ahn, HJ Chon, SJ Shin, JB Ahn, HC Chung, ... Cancer research and treatment: official journal of Korean Cancer Association …, 2009 | 83 | 2009 |
| Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment … SK Pal, L Albiges, P Tomczak, C Suárez, MH Voss, G de Velasco, ... The Lancet 402 (10397), 185-195, 2023 | 62 | 2023 |
| Clinical value of ezrin expression in primary osteosarcoma C Kim, E Shin, S Hong, HJ Chon, HR Kim, JR Ahn, MH Hong, WI Yang, ... Cancer research and treatment: official journal of Korean Cancer Association …, 2009 | 62 | 2009 |
| Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients SM Lim, YN Kim, KH Park, B Kang, HJ Chon, C Kim, JH Kim, SY Rha BMC cancer 16, 1-7, 2016 | 61 | 2016 |
| STING signaling is a potential immunotherapeutic target in colorectal cancer HJ Chon, H Kim, JH Noh, H Yang, WS Lee, SJ Kong, SJ Lee, YS Lee, ... Journal of Cancer 10 (20), 4932, 2019 | 60 | 2019 |
| Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites B Lim, C Kim, JH Kim, WS Kwon, WS Lee, JM Kim, JY Park, HS Kim, ... Oncotarget 7 (7), 8055, 2016 | 59 | 2016 |
| STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer SJ Lee, H Yang, WR Kim, YS Lee, WS Lee, SJ Kong, HJ Lee, JH Kim, ... Journal for Immunotherapy of Cancer 9 (6), 2021 | 55 | 2021 |
| Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer C Kim, HJ Chon, B Kang, K Kim, HC Jeung, HC Chung, SH Noh, SY Rha BMC cancer 13, 1-7, 2013 | 54 | 2013 |
Hong Jae ChonCHA University of School of MedicineVerified email at cha.ac.kr
